Correlation Between Acorda Therapeutics and Sunshine Biopharma

Can any of the company-specific risk be diversified away by investing in both Acorda Therapeutics and Sunshine Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acorda Therapeutics and Sunshine Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acorda Therapeutics and Sunshine Biopharma, you can compare the effects of market volatilities on Acorda Therapeutics and Sunshine Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acorda Therapeutics with a short position of Sunshine Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acorda Therapeutics and Sunshine Biopharma.

Diversification Opportunities for Acorda Therapeutics and Sunshine Biopharma

0.01

Correlation Coefficient

Acorda Therapeutics  Sunshine Biopharma

Significant diversification

The 3 months correlation between Acorda and Sunshine is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Acorda Therapeutics and Sunshine Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunshine Biopharma and Acorda Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acorda Therapeutics are associated (or correlated) with Sunshine Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunshine Biopharma has no effect on the direction of Acorda Therapeutics i.e., Acorda Therapeutics and Sunshine Biopharma go up and down completely randomly.

Pair Corralation between Acorda Therapeutics and Sunshine Biopharma

If you would invest  257.00  in Sunshine Biopharma on September 15, 2024 and sell it today you would earn a total of  18.00  from holding Sunshine Biopharma or generate 7.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	4.76%
Values	Daily Returns

Acorda Therapeutics  vs.  Sunshine Biopharma

Acorda Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Acorda Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Acorda Therapeutics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Sunshine Biopharma

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sunshine Biopharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Sunshine Biopharma may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Acorda Therapeutics and Sunshine Biopharma

The main advantage of trading using opposite Acorda Therapeutics and Sunshine Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acorda Therapeutics position performs unexpectedly, Sunshine Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will offset losses from the drop in Sunshine Biopharma's long position.

The idea behind Acorda Therapeutics and Sunshine Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.